{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:07:12Z","timestamp":1793117232218,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical university","award":["NO. 2022QH2020"],"award-info":[{"award-number":["NO. 2022QH2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12272-025-01570-0","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T15:33:44Z","timestamp":1758468824000},"page":"831-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Histone lactylation in gastrointestinal cancers: developing immunotherapeutic drugs targeting epigenetics"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-2169","authenticated-orcid":false,"given":"Mingyao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,21]]},"reference":[{"issue":"5","key":"1570_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2014.16","volume":"3","author":"SJ Allison","year":"2014","unstructured":"Allison SJ, Knight JR, Granchi C, Rani R, Minutolo F, Milner J, Phillips RM (2014) Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53\/NAD(H)-dependent and (ii) p53-independent pathways. Oncogenesis 3(5):e102. https:\/\/doi.org\/10.1038\/oncsis.2014.16","journal-title":"Oncogenesis"},{"issue":"6","key":"1570_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","volume":"28","author":"M Apicella","year":"2018","unstructured":"Apicella M, Giannoni E, Fiore S, Ferrari KJ, Fernandez-Perez D, Isella C, Granchi C, Minutolo F, Sottile A, Comoglio PM, Medico E, Pietrantonio F, Volante M, Pasini D, Chiarugi P, Giordano S, Corso S (2018) Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies. Cell Metab 28(6):848-865.e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.006","journal-title":"Cell Metab"},{"issue":"13","key":"1570_CR3","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1039\/d1cs00991e","volume":"51","author":"T Bilbrough","year":"2022","unstructured":"Bilbrough T, Piemontese E, Seitz O (2022) Dissecting the role of protein phosphorylation: a chemical biology toolbox. Chem Soc Rev 51(13):5691\u20135730. https:\/\/doi.org\/10.1039\/d1cs00991e","journal-title":"Chem Soc Rev"},{"key":"1570_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, Chen S, Du J, Wang B, Cai Y, Yang Y, Wan J, Zhou J, Fan J, Dai Z (2024) Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun (Lond) 44:1231\u20131260. https:\/\/doi.org\/10.1002\/cac2.12607","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"1570_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957","volume":"8","author":"JM Chauvin","year":"2020","unstructured":"Chauvin JM, Zarour HM (2020) Tigit in cancer immunotherapy. J Immunother Cancer 8(2):e000957. https:\/\/doi.org\/10.1136\/jitc-2020-000957","journal-title":"J Immunother Cancer"},{"issue":"2","key":"1570_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591\u2013605. https:\/\/doi.org\/10.1038\/s41418-020-00708-5","journal-title":"Cell Death Differ"},{"key":"1570_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216896","volume":"591","author":"E Dai","year":"2024","unstructured":"Dai E, Wang W, Li Y, Ye D, Li Y (2024) Lactate and lactylation: behind the development of tumors. Cancer Lett 591:216896. https:\/\/doi.org\/10.1016\/j.canlet.2024.216896","journal-title":"Cancer Lett"},{"issue":"4","key":"1570_CR8","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41375-020-01010-6","volume":"35","author":"MS Davids","year":"2021","unstructured":"Davids MS, Fisher DC, Tyekucheva S, McDonough M, Hanna J, Lee B, Francoeur K, Montegaard J, Odejide O, Armand P, Arnason J, Brown JR (2021) A phase 1b\/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients. Leukemia 35(4):1064\u20131072. https:\/\/doi.org\/10.1038\/s41375-020-01010-6","journal-title":"Leukemia"},{"issue":"5","key":"1570_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, Pace A, D\u2019Angelo L, Liu JKC, Etame AB, Rughetti A, Nuti M, Santoro A, Vogelbaum MA, Conejo-Garcia JR, Rodriguez PC, Veglia F (2024) Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity 57(5):1105-1123.e8. https:\/\/doi.org\/10.1016\/j.immuni.2024.04.006","journal-title":"Immunity"},{"key":"1570_CR10","doi-asserted-by":"publisher","first-page":"1495221","DOI":"10.3389\/fimmu.2024.1495221","volume":"15","author":"X Duan","year":"2024","unstructured":"Duan X, Xing Z, Qiao L, Qin S, Zhao X, Gong Y, Li X (2024) The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications. Front Immunol 15:1495221. https:\/\/doi.org\/10.3389\/fimmu.2024.1495221","journal-title":"Front Immunol"},{"issue":"7750","key":"1570_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","volume":"568","author":"I Elia","year":"2019","unstructured":"Elia I, Rossi M, Stegen S, Broekaert D, Doglioni G, van Gorsel M, Boon R, Escalona-Noguero C, Torrekens S, Verfaillie C, Verbeken E, Carmeliet G, Fendt SM (2019) Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature 568(7750):117\u2013121. https:\/\/doi.org\/10.1038\/s41586-019-0977-x","journal-title":"Nature"},{"issue":"4","key":"1570_CR12","doi-asserted-by":"publisher","first-page":"E330","DOI":"10.1152\/ajpendo.00159.2022","volume":"324","author":"H Fan","year":"2023","unstructured":"Fan H, Yang F, Xiao Z, Luo H, Chen H, Chen Z, Liu Q, Xiao Y (2023) Lactylation: novel epigenetic regulatory and therapeutic opportunities. Am J Physiol Endocrinol Metab 324(4):E330\u2013E338. https:\/\/doi.org\/10.1152\/ajpendo.00159.2022","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8\u20139","key":"1570_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/1751-2980.13218","volume":"24","author":"Y Fang","year":"2023","unstructured":"Fang Y, Lu ZH, Liu BZ, Li N, Yang MZ, Wang P (2023) IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35. J Dig Dis 24(8\u20139):480\u2013490. https:\/\/doi.org\/10.1111\/1751-2980.13218","journal-title":"J Dig Dis"},{"key":"1570_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2084195","volume":"2019","author":"RG Feichtinger","year":"2019","unstructured":"Feichtinger RG, Lang R (2019) Targeting L-lactate metabolism to overcome resistance to immune therapy of melanoma and other tumor entities. J Oncol 2019:2084195. https:\/\/doi.org\/10.1155\/2019\/2084195","journal-title":"J Oncol"},{"issue":"42","key":"1570_CR15","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1038\/onc.2017.188","volume":"36","author":"J Feng","year":"2017","unstructured":"Feng J, Yang H, Zhang Y, Wei H, Zhu Z, Zhu B, Yang M, Cao W, Wang L, Wu Z (2017) Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene 36(42):5829\u20135839. https:\/\/doi.org\/10.1038\/onc.2017.188","journal-title":"Oncogene"},{"issue":"2","key":"1570_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.chembiol.2019.11.005","volume":"27","author":"DO Gaffney","year":"2020","unstructured":"Gaffney DO, Jennings EQ, Anderson CC, Marentette JO, Shi T, Schou Oxvig AM, Streeter MD, Johannsen M, Spiegel DA, Chapman E, Roede JR, Galligan JJ (2020) Non-enzymatic lysine lactoylation of glycolytic enzymes. Cell Chem Biol 27(2):206-213.e6. https:\/\/doi.org\/10.1016\/j.chembiol.2019.11.005","journal-title":"Cell Chem Biol"},{"key":"1570_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102188","volume":"51","author":"B Gao","year":"2025","unstructured":"Gao B, Gou X, Feng C, Zhang Y, Gu H, Chai F, Wang Y, Ye Y, Hong N, Hu G, Sun B, Cheng J, Yang H (2025) Identification of cancer-associated fibroblast subtypes and distinctive role of MFAP5 in CT-detected extramural venous invasion in gastric cancer. Transl Oncol 51:102188. https:\/\/doi.org\/10.1016\/j.tranon.2024.102188","journal-title":"Transl Oncol"},{"issue":"12","key":"1570_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, Shao Q, Zhou B, Zhou H, Wei S, Wang Q, Liang Y, Lu L (2022) Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep 39(12):110986. https:\/\/doi.org\/10.1016\/j.celrep.2022.110986","journal-title":"Cell Rep"},{"issue":"31","key":"1570_CR100","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1038\/s41388-024-03080-7","volume":"43","author":"J Gu","year":"2024","unstructured":"Gu J, Xu X, Li X, Yue L, Zhu X, Chen Q, Gao J, Takashi M, Zhao W, Zhao B, Zhang Y, Lin M, Zhou J, Liang Y, Dai S, Pan Y, Shao Q, Li Y, Wang Y, Xu Z, Qian Q, Huang T, Qian X, Lu L (2024) Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation. Oncogene 43(31):2389\u20132404","journal-title":"Oncogene"},{"issue":"11","key":"1570_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70070","volume":"14","author":"Y He","year":"2024","unstructured":"He Y, Song T, Ning J, Wang Z, Yin Z, Jiang P, Yuan Q, Yu W, Cheng F (2024) Lactylation in cancer: mechanisms in tumour biology and therapeutic potentials. Clin Transl Med 14(11):e70070. https:\/\/doi.org\/10.1002\/ctm2.70070","journal-title":"Clin Transl Med"},{"key":"1570_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.11.010","author":"XT Hu","year":"2024","unstructured":"Hu XT, Wu XF, Xu JY, Xu X (2024a) Lactate-mediated lactylation in human health and diseases: progress and remaining challenges. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2024.11.010","journal-title":"J Adv Res"},{"issue":"1","key":"1570_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, Zhou Z, Hu Q, Cong X (2024b) Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics 16(1):72. https:\/\/doi.org\/10.1186\/s13148-024-01682-2","journal-title":"Clin Epigenetics"},{"issue":"1","key":"1570_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, Xu JQ, Liu Q, Long ZJ (2023) STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther 8(1):391. https:\/\/doi.org\/10.1038\/s41392-023-01605-2","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"1570_CR23","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/cbic.202000883","volume":"22","author":"EQ Jennings","year":"2021","unstructured":"Jennings EQ, Ray JD, Zerio CJ, Trujillo MN, McDonald DM, Chapman E, Spiegel DA, Galligan JJ (2021) Sirtuin 2 regulates protein lactoylLys modifications. ChemBioChem 22(12):2102\u20132106. https:\/\/doi.org\/10.1002\/cbic.202000883","journal-title":"ChemBioChem"},{"key":"1570_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104586","volume":"206","author":"P Ji","year":"2025","unstructured":"Ji P, Chen T, Li C, Zhang J, Li X, Zhu H (2025) Comprehensive review of signaling pathways and therapeutic targets in gastrointestinal cancers. Crit Rev Oncol Hematol 206:104586. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104586","journal-title":"Crit Rev Oncol Hematol"},{"key":"1570_CR25","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0918","author":"X Jiang","year":"2024","unstructured":"Jiang X, Yang Y, Li X, Li T, Yu T, Fu X (2024) Lactylation: an innovative approach to disease control. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2024.0918","journal-title":"Aging Dis"},{"issue":"1","key":"1570_CR26","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28862","volume":"3","author":"M Jinushi","year":"2014","unstructured":"Jinushi M (2014) Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments. Oncoimmunology 3(1):e28862. https:\/\/doi.org\/10.4161\/onci.28862","journal-title":"Oncoimmunology"},{"key":"1570_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107634","volume":"96","author":"K Kang","year":"2021","unstructured":"Kang K, Xia A, Meng F, Chunyu J, Sun X, Ren G, Yu D, Jiang X, Tang L, Xiao W, Li D (2021) FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages. Int Immunopharmacol 96:107634. https:\/\/doi.org\/10.1016\/j.intimp.2021.107634","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1570_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0154-8","volume":"9","author":"JL Kaufman","year":"2019","unstructured":"Kaufman JL, Mina R, Jakubowiak AJ, Zimmerman TL, Wolf JJ, Lewis C, Gleason C, Sharp C, Martin T, Heffner LT, Nooka AK, Harvey RD, Lonial S (2019) Combining carfilzomib and panobinostat to treat relapsed\/refractory multiple myeloma: results of a multiple myeloma research consortium phase i study. Blood Cancer J 9(1):3. https:\/\/doi.org\/10.1038\/s41408-018-0154-8","journal-title":"Blood Cancer J"},{"key":"1570_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111522","volume":"126","author":"W Khan","year":"2025","unstructured":"Khan W, Zeb A, Malik MFA, Wahid M, Mandal RK, Babegi AS, Mathkor DM, Haque S, Haq F (2025) FGF21 affects the glycolysis process via mTOR-HIF1\u03b1 axis in hepatocellular carcinoma. Cell Signal 126:111522. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111522","journal-title":"Cell Signal"},{"issue":"1","key":"1570_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08150-3","volume":"7","author":"J Kinross","year":"2017","unstructured":"Kinross J, Mirnezami R, Alexander J, Brown R, Scott A, Galea D, Veselkov K, Goldin R, Darzi A, Nicholson J, Marchesi JR (2017) A prospective analysis of mucosal microbiome-metabonome interactions in colorectal cancer using a combined MAS 1H NMR and metataxonomic strategy. Sci Rep 7(1):8979. https:\/\/doi.org\/10.1038\/s41598-017-08150-3","journal-title":"Sci Rep"},{"issue":"18","key":"1570_CR31","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.2174\/0929867324666170209103444","volume":"26","author":"G Lagana","year":"2019","unstructured":"Lagana G, Barreca D, Calderaro A, Bellocco E (2019) Lactate dehydrogenase inhibition: biochemical relevance and therapeutical potential. Curr Med Chem 26(18):3242\u20133252. https:\/\/doi.org\/10.2174\/0929867324666170209103444","journal-title":"Curr Med Chem"},{"issue":"5","key":"1570_CR32","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107(5):2037\u20132042. https:\/\/doi.org\/10.1073\/pnas.0914433107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1570_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, Cui X, Yang J, Hong T, Wei R (2024a) Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer 23(1):90. https:\/\/doi.org\/10.1186\/s12943-024-02008-9","journal-title":"Mol Cancer"},{"key":"1570_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111468","volume":"124","author":"J Li","year":"2024","unstructured":"Li J, Chen Z, Jin M, Gu X, Wang Y, Huang G, Zhao W, Lu C (2024b) Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cell Signal 124:111468. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111468","journal-title":"Cell Signal"},{"issue":"2","key":"1570_CR35","doi-asserted-by":"publisher","first-page":"C487","DOI":"10.1152\/ajpcell.00124.2024","volume":"327","author":"M Li","year":"2024","unstructured":"Li M, Sun P, Tu B, Deng G, Li D, He W (2024c) Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner. Am J Physiol Cell Physiol 327(2):C487\u2013C504. https:\/\/doi.org\/10.1152\/ajpcell.00124.2024","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1570_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113688","volume":"43","author":"XM Li","year":"2024","unstructured":"Li XM, Yang Y, Jiang FQ, Hu G, Wan S, Yan WY, He XS, Xiao F, Yang XM, Guo X, Lu JH, Yang XQ, Chen JJ, Ye WL, Liu Y, He K, Duan HX, Zhou YJ, Gan WJ, Liu F, Wu H (2024d) Histone lactylation inhibits RAR\u03b3 expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Rep 43(2):113688. https:\/\/doi.org\/10.1016\/j.celrep.2024.113688","journal-title":"Cell Rep"},{"key":"1570_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116982","volume":"177","author":"Y Li","year":"2024","unstructured":"Li Y, Cao Q, Hu Y, He B, Cao T, Tang Y, Zhou XP, Lan XP, Liu SQ (2024e) Advances in the interaction of glycolytic reprogramming with lactylation. Biomed Pharmacother 177:116982. https:\/\/doi.org\/10.1016\/j.biopha.2024.116982","journal-title":"Biomed Pharmacother"},{"key":"1570_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111462","volume":"124","author":"Z Li","year":"2024","unstructured":"Li Z, Liang P, Chen Z, Chen Z, Jin T, He F, Chen X, Yang K (2024f) CAF-secreted LOX promotes PD-L1 expression via histone lactylation and regulates tumor EMT through TGF-\u03b2\/IGF1 signaling in gastric cancer. Cell Signal 124:111462. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111462","journal-title":"Cell Signal"},{"issue":"Pt 3","key":"1570_CR39","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.semcancer.2022.10.009","volume":"86","author":"J Lin","year":"2022","unstructured":"Lin J, Liu G, Chen L, Kwok HF, Lin Y (2022) Targeting lactate-related cell cycle activities for cancer therapy. Semin Cancer Biol 86(Pt 3):1231\u20131243. https:\/\/doi.org\/10.1016\/j.semcancer.2022.10.009","journal-title":"Semin Cancer Biol"},{"key":"1570_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.972020","volume":"10","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Li W, Zhou X (2022) Lactylation, an emerging hallmark of metabolic reprogramming: current progress and open challenges. Front Cell Dev Biol 10:972020. https:\/\/doi.org\/10.3389\/fcell.2022.972020","journal-title":"Front Cell Dev Biol"},{"key":"1570_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01423-1","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu P, Duan S, Lin J, Qi W, Yu Z, Gao X, Sun X, Liu J, Lin J, Zhai S, Qin K, Cao Y, Li J, Liu Y, Chen M, Zou S, Wen C, Wang J, Fu D, Wang J, Bao H, Sun K, Jiang Y, Shen B (2024) CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-024-01423-1","journal-title":"Cell Death Differ"},{"issue":"1","key":"1570_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biom15010071","volume":"15","author":"K Liu","year":"2025","unstructured":"Liu K, Li Y, Shen M, Xu W, Wu S, Yang X, Zhang B, Lin N (2025) Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment. Biomolecules 15(1):71. https:\/\/doi.org\/10.3390\/biom15010071","journal-title":"Biomolecules"},{"key":"1570_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-031-61238-1_14","volume":"192","author":"H Lote","year":"2024","unstructured":"Lote H, Chau I (2024) Immunotherapy in gastrointestinal cancers. Cancer Treat Res 192:277\u2013303. https:\/\/doi.org\/10.1007\/978-3-031-61238-1_14","journal-title":"Cancer Treat Res"},{"key":"1570_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100964","volume":"79","author":"A Magalhaes","year":"2021","unstructured":"Magalhaes A, Duarte HO, Reis CA (2021) The role of O-glycosylation in human disease. Mol Aspects Med 79:100964. https:\/\/doi.org\/10.1016\/j.mam.2021.100964","journal-title":"Mol Aspects Med"},{"issue":"2","key":"1570_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cmdc.201100471","volume":"7","author":"M Manerba","year":"2012","unstructured":"Manerba M, Vettraino M, Fiume L, Di Stefano G, Sartini A, Giacomini E, Buonfiglio R, Roberti M, Recanatini M (2012) Galloflavin (CAS 568\u201380-9): a novel inhibitor of lactate dehydrogenase. ChemMedChem 7(2):311\u2013317. https:\/\/doi.org\/10.1002\/cmdc.201100471","journal-title":"ChemMedChem"},{"issue":"7","key":"1570_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A (2022) DNA methylation: a historical perspective. Trends Genet 38(7):676\u2013707. https:\/\/doi.org\/10.1016\/j.tig.2022.03.010","journal-title":"Trends Genet"},{"issue":"9","key":"1570_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091372","volume":"11","author":"GH Mohammad","year":"2019","unstructured":"Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP (2019) Targeting pyruvate kinase M2 and lactate dehydrogenase A is an effective combination strategy for the treatment of pancreatic cancer. Cancers 11(9):1372. https:\/\/doi.org\/10.3390\/cancers11091372","journal-title":"Cancers"},{"issue":"3","key":"1570_CR48","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J, Dankova D, Nielsen AL, Bolding JE, Yang L, Jameson ST, Wong J, Olsen CA, Zhao Y (2022) Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases. Sci Adv 8(3):6696. https:\/\/doi.org\/10.1126\/sciadv.abi6696","journal-title":"Sci Adv"},{"issue":"1","key":"1570_CR49","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","volume":"15","author":"Z Niu","year":"2024","unstructured":"Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A, Mo J, Zhang J, Han Y, Yuan Y, Zhang Y, Zang Y, He C, Bai X, Tian S, Zhai G, Wu X, Zhang K (2024) HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat Commun 15(1):3561. https:\/\/doi.org\/10.1038\/s41467-024-47900-6","journal-title":"Nat Commun"},{"issue":"23","key":"1570_CR50","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2014.59.2782","volume":"33","author":"OA O\u2019Connor","year":"2015","unstructured":"O\u2019Connor OA, Horwitz S, Masszi T, Van Hoof A, Brown P, Doorduijn J, Hess G, Jurczak W, Knoblauch P, Chawla S, Bhat GR, Choi MR, Walewski J, Savage K, Foss F, Allen LF, Shustov A (2015) Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) study. J Clin Oncol 33(23):2492\u20132499. https:\/\/doi.org\/10.1200\/JCO.2014.59.2782","journal-title":"J Clin Oncol"},{"issue":"6","key":"1570_CR51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjh.12819","volume":"165","author":"M Ogura","year":"2014","unstructured":"Ogura M, Ando K, Suzuki T, Ishizawa K, Oh SY, Itoh K, Yamamoto K, Au WY, Tien HF, Matsuno Y, Terauchi T, Yamamoto K, Mori M, Tanaka Y, Shimamoto T, Tobinai K, Kim WS (2014) A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Br J Haematol 165(6):768\u2013776. https:\/\/doi.org\/10.1111\/bjh.12819","journal-title":"Br J Haematol"},{"key":"1570_CR52","doi-asserted-by":"publisher","first-page":"1340124","DOI":"10.3389\/fmolb.2024.1340124","volume":"11","author":"E Ozmen","year":"2024","unstructured":"Ozmen E, Demir TD, Ozcan G (2024) Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer. Front Mol Biosci 11:1340124. https:\/\/doi.org\/10.3389\/fmolb.2024.1340124","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1570_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-024-00591-7","volume":"14","author":"H Peng","year":"2025","unstructured":"Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S, Guo X, Zhang J, Zhou Q, Qu G, Gao Y, Luo J, Wang Z, Wang J, Li L (2025) Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications. Exp Hematol Oncol 14(1):4. https:\/\/doi.org\/10.1186\/s40164-024-00591-7","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"1570_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari BR, Zhang D, Allis CD, Zhao Y (2017) Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol 18(2):90\u2013101. https:\/\/doi.org\/10.1038\/nrm.2016.140","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1570_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071049","volume":"12","author":"K Shimozaki","year":"2023","unstructured":"Shimozaki K, Nakayama I, Hirota T, Yamaguchi K (2023) Current strategy to treat immunogenic gastrointestinal cancers: perspectives for a new era. Cells 12(7):1049. https:\/\/doi.org\/10.3390\/cells12071049","journal-title":"Cells"},{"issue":"5","key":"1570_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A (2022) Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol 23(5):329\u2013349. https:\/\/doi.org\/10.1038\/s41580-021-00441-y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1570_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/imr.12846","volume":"295","author":"PJ Siska","year":"2020","unstructured":"Siska PJ, Singer K, Evert K, Renner K, Kreutz M (2020) The immunological warburg effect: can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy? Immunol Rev 295(1):187\u2013202. https:\/\/doi.org\/10.1111\/imr.12846","journal-title":"Immunol Rev"},{"issue":"4","key":"1570_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.semnephrol.2019.04.007","volume":"39","author":"NY Spencer","year":"2019","unstructured":"Spencer NY, Stanton RC (2019) The Warburg effect, lactate, and nearly a century of trying to cure cancer. Semin Nephrol 39(4):380\u2013393. https:\/\/doi.org\/10.1016\/j.semnephrol.2019.04.007","journal-title":"Semin Nephrol"},{"key":"1570_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1485580","volume":"14","author":"X Sun","year":"2024","unstructured":"Sun X, Dong H, Su R, Chen J, Li W, Yin S, Zhang C (2024a) Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer. Front Oncol 14:1485580. https:\/\/doi.org\/10.3389\/fonc.2024.1485580","journal-title":"Front Oncol"},{"key":"1570_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116802","volume":"278","author":"Z Sun","year":"2024","unstructured":"Sun Z, Liu L, Chen J (2024b) Targeting non-histone methylation in gastrointestinal cancers: from biology to clinic. Eur J Med Chem 278:116802. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116802","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1570_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020510","volume":"9","author":"ML Taddei","year":"2020","unstructured":"Taddei ML, Pietrovito L, Leo A, Chiarugi P (2020) Lactate in sarcoma microenvironment: much more than just a waste product. Cells 9(2):510. https:\/\/doi.org\/10.3390\/cells9020510","journal-title":"Cells"},{"issue":"6","key":"1570_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/cac2.12546","volume":"44","author":"Y Tang","year":"2024","unstructured":"Tang Y, Cui G, Liu H, Han Y, Cai C, Feng Z, Shen H, Zeng S (2024) Converting \u201ccold\u201d to \u201chot\u201d: Epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells. Cancer Commun (Lond) 44(6):601\u2013636. https:\/\/doi.org\/10.1002\/cac2.12546","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"1570_CR63","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang L, Li S, Luo H, Lu Q, Yu S (2022) PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res 41(1):303. https:\/\/doi.org\/10.1186\/s13046-022-02477-0","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1570_CR64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s13402-023-00775-z","volume":"46","author":"JH Wang","year":"2023","unstructured":"Wang JH, Mao L, Wang J, Zhang X, Wu M, Wen Q, Yu SC (2023) Beyond metabolic waste: Lysine lactylation and its potential roles in cancer progression and cell fate determination. Cell Oncol (Dordr) 46(3):465\u2013480. https:\/\/doi.org\/10.1007\/s13402-023-00775-z","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"1570_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05991-1","volume":"22","author":"F Wang","year":"2024","unstructured":"Wang F, Yang C, Zheng F, Yan Y, Li G, Feng Y, Xu H, He Z, Cai D, Sun H, Qi X, Mao Y (2024a) METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer. J Transl Med 22(1):1161. https:\/\/doi.org\/10.1186\/s12967-024-05991-1","journal-title":"J Transl Med"},{"issue":"1","key":"1570_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12935-024-03429-8","volume":"24","author":"G Wang","year":"2024","unstructured":"Wang G, Zou X, Chen Q, Nong W, Miao W, Luo H, Qu S (2024b) The relationship and clinical significance of lactylation modification in digestive system tumors. Cancer Cell Int 24(1):246. https:\/\/doi.org\/10.1186\/s12935-024-03429-8","journal-title":"Cancer Cell Int"},{"key":"1570_CR67","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2147\/JHC.S458734","volume":"11","author":"J Wang","year":"2024","unstructured":"Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y (2024c) Research progress on the role of epigenetic methylation modification in hepatocellular carcinoma. J Hepatocell Carcinoma 11:1143\u20131156. https:\/\/doi.org\/10.2147\/JHC.S458734","journal-title":"J Hepatocell Carcinoma"},{"key":"1570_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217117","volume":"598","author":"X Wang","year":"2024","unstructured":"Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu M, Luo X, Jiang D, Tang Y, You L, Zhao Y (2024d) Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Lett 598:217117. https:\/\/doi.org\/10.1016\/j.canlet.2024.217117","journal-title":"Cancer Lett"},{"issue":"1","key":"1570_CR69","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12974-024-03303-4","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li P, Xu Y, Feng L, Fang Y, Song G, Xu L, Zhu Z, Wang W, Mei Q, Xie M (2024e) Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms. J Neuroinflammation 21(1):308. https:\/\/doi.org\/10.1186\/s12974-024-03303-4","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1570_CR70","doi-asserted-by":"publisher","first-page":"18642","DOI":"10.1038\/s41598-023-46057-4","volume":"13","author":"Q Wu","year":"2023","unstructured":"Wu Q, Li X, Long M, Xie X, Liu Q (2023) Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. Sci Rep 13(1):18642. https:\/\/doi.org\/10.1038\/s41598-023-46057-4","journal-title":"Sci Rep"},{"issue":"8","key":"1570_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, Wu Y, Deng W, Ma J, Li X, Pan B, Zhang B, Zhang H, Luo A, Xu Y, Li M, Pu Y (2024) KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci U S A 121(8):e2314128121. https:\/\/doi.org\/10.1073\/pnas.2314128121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1570_CR72","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/labinvest.2009.11","volume":"89","author":"H Xiong","year":"2009","unstructured":"Xiong H, Su WY, Liang QC, Zhang ZG, Chen HM, Du W, Chen YX, Fang JY (2009) Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells. Lab Invest 89(6):717\u2013725. https:\/\/doi.org\/10.1038\/labinvest.2009.11","journal-title":"Lab Invest"},{"issue":"9","key":"1570_CR73","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, Xue M, Zheng W, Kong X, Jiang K, Ding K, Lai L, Wang Q (2022) Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell 82(9):1660-1677.e10. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.033","journal-title":"Mol Cell"},{"key":"1570_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116331","volume":"225","author":"K Xu","year":"2024","unstructured":"Xu K, Zhang K, Wang Y, Gu Y (2024) Comprehensive review of histone lactylation: structure, function, and therapeutic targets. Biochem Pharmacol 225:116331. https:\/\/doi.org\/10.1016\/j.bcp.2024.116331","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1570_CR75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, Gill PS, Ha T, Liu L, Williams DL, Li C (2022) Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ 29(1):133\u2013146. https:\/\/doi.org\/10.1038\/s41418-021-00841-9","journal-title":"Cell Death Differ"},{"key":"1570_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149989","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Zou X, Yang S, Zhang A, Li N, Ma Z (2023) Identification of lactylation-related model to predict prognostic, tumor-infiltrating immunocytes and response of immunotherapy in gastric cancer. Front Immunol 14:1149989. https:\/\/doi.org\/10.3389\/fimmu.2023.1149989","journal-title":"Front Immunol"},{"issue":"21","key":"1570_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38426","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang Y, Luo N, Gong Z, Zhou W, Ku Y, Chen Y (2024) Lactate and lysine lactylation of histone regulate transcription in cancer. Heliyon 10(21):e38426. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38426","journal-title":"Heliyon"},{"issue":"1","key":"1570_CR78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R (2021) Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol 22(1):85. https:\/\/doi.org\/10.1186\/s13059-021-02308-z","journal-title":"Genome Biol"},{"key":"1570_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217385","volume":"611","author":"H Yu","year":"2024","unstructured":"Yu H, Li J, Peng S, Liu Q, Chen D, He Z, Xiang J, Wang B (2024) Tumor microenvironment: nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy. Cancer Lett 611:217385. https:\/\/doi.org\/10.1016\/j.canlet.2024.217385","journal-title":"Cancer Lett"},{"issue":"6","key":"1570_CR80","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1021\/acschembio.1c00863","volume":"17","author":"M Zessin","year":"2022","unstructured":"Zessin M, Meleshin M, Praetorius L, Sippl W, Barinka C, Schutkowski M (2022) Uncovering robust delactoylase and depyruvoylase activities of HDAC isoforms. ACS Chem Biol 17(6):1364\u20131375. https:\/\/doi.org\/10.1021\/acschembio.1c00863","journal-title":"ACS Chem Biol"},{"key":"1570_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1384948","volume":"15","author":"J Zha","year":"2024","unstructured":"Zha J, Zhang J, Lu J, Zhang G, Hua M, Guo W, Yang J, Fan G (2024) A review of lactate-lactylation in malignancy: its potential in immunotherapy. Front Immunol 15:1384948. https:\/\/doi.org\/10.3389\/fimmu.2024.1384948","journal-title":"Front Immunol"},{"issue":"7779","key":"1570_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574(7779):575\u2013580. https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"issue":"21","key":"1570_CR83","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, Zheng L (2024a) H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res 84(21):3589\u20133601. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3513","journal-title":"Cancer Res"},{"issue":"12","key":"1570_CR84","doi-asserted-by":"publisher","first-page":"10005","DOI":"10.1021\/acs.jmedchem.4c00140","volume":"67","author":"XW Zhang","year":"2024","unstructured":"Zhang XW, Li L, Liao M, Liu D, Rehman A, Liu Y, Liu ZP, Tu PF, Zeng KW (2024b) Thermal proteome profiling strategy identifies CNPY3 as a cellular target of gambogic acid for inducing prostate cancer pyroptosis. J Med Chem 67(12):10005\u201310011. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00140","journal-title":"J Med Chem"},{"issue":"10","key":"1570_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108487","volume":"33","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, Cai K, Zhao Y, Luo Z (2020) HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep 33(10):108487. https:\/\/doi.org\/10.1016\/j.celrep.2020.108487","journal-title":"Cell Rep"},{"key":"1570_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107933","volume":"99","author":"L Zhao","year":"2021","unstructured":"Zhao L, Cheng S, Fan L, Zhang B, Xu S (2021) TIM-3: an update on immunotherapy. Int Immunopharmacol 99:107933. https:\/\/doi.org\/10.1016\/j.intimp.2021.107933","journal-title":"Int Immunopharmacol"},{"key":"1570_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116120","volume":"222","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Jiang J, Zhou P, Deng K, Liu Z, Yang M, Yang X, Li J, Li R, Xia J (2024) H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis. Biochem Pharmacol 222:116120. https:\/\/doi.org\/10.1016\/j.bcp.2024.116120","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1570_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44779-1","volume":"15","author":"C Zhou","year":"2024","unstructured":"Zhou C, Li W, Liang Z, Wu X, Cheng S, Peng J, Zeng K, Li W, Lan P, Yang X, Xiong L, Zeng Z, Zheng X, Huang L, Fan W, Liu Z, Xing Y, Kang L, Liu H (2024a) Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. Nat Commun 15(1):499. https:\/\/doi.org\/10.1038\/s41467-024-44779-1","journal-title":"Nat Commun"},{"issue":"9","key":"1570_CR89","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13258-024-01554-2","volume":"46","author":"J Zhou","year":"2024","unstructured":"Zhou J, Ma X, Liu X, Liu Y, Fu J, Qi Y, Liu H (2024b) The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy. Genes Genomics 46(9):991\u20131011. https:\/\/doi.org\/10.1007\/s13258-024-01554-2","journal-title":"Genes Genomics"},{"issue":"1","key":"1570_CR90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-022-00398-y","volume":"8","author":"H Zu","year":"2022","unstructured":"Zu H, Li C, Dai C, Pan Y, Ding C, Sun H, Zhang X, Yao X, Zang J, Mo X (2022) SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov 8(1):54. https:\/\/doi.org\/10.1038\/s41421-022-00398-y","journal-title":"Cell Discov"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-025-01570-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-025-01570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:58:16Z","timestamp":1762318696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-025-01570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,21]]},"references-count":91,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1007\/s12272-025-01570-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,21]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}